Response to lorlatinib on a patient with ALK‐rearranged non‐small cell lung cancer harboring 1151Tins mutation with uterine metastasis

by Takashi Kobayashi, Shintaro Kanda, Toshirou Fukushima, Takuro Noguchi, Nodoka Sekiguchi, Tomonobu Koizumi
Published 2021-08-01

Clinical utility of the C‐reactive protein:albumin ratio in non‐small cell lung cancer patients treated with nivolumab

by Taisuke Araki, Kazunari Tateishi, Kei Sonehara, Shuko Hirota, Masamichi Komatsu, Manabu Yamamoto, Shintaro Kanda, Hiroshi Kuraishi, Masayuki Hanaoka, Tomonobu Koizumi
Published 2021-03-01

Serial Cancer Development Three Times in a Patient with Fanconi Anemia

by Katsuya Yanagisawa, Toshimichi Horiuchi, Akemi Matsuo, Hiroshi Kuraishi, Hidetoshi Satomi, Ichiro Ito, Takuro Noguchi, Nodoka Sekiguchi, Shintaro Kanda, Tomonobu Koizumi
Published 2021-08-01

Primary mediastinal germ cell tumors ‐ A retrospective analysis of >30 years of experience in a single institution

by Tomonobu Koizumi, Shintaro Kanda, Ryo Nihonmatu, Daisuke Gomi, Nodoka Sekiguchi, Takuro Noguchi, Toshirou Fukushima, Takashi Kobayashi, Hiroshi Yamamoto, Tetsu Takeda
Published 2021-03-01

Number of metastatic organs negatively affects the treatment sequence in patients with EGFR‐TKI failure

by Takaaki Mizuno, Hidehito Horinouchi, Sho Watanabe, Jun Sato, Ryo Morita, Shuji Murakami, Yasushi Goto, Shintaro Kanda, Yutaka Fujiwara, Noboru Yamamoto, Yuichiro Ohe
Published 2020-04-01

Mixed response to osimertinib and the beneficial effects of additional local therapy

by Yuki Shinno, Yasushi Goto, Jun Sato, Ryo Morita, Yuji Matsumoto, Shuji Murakami, Shintaro Kanda, Hidehito Horinouchi, Yutaka Fujiwara, Noboru Yamamoto, Yuichiro Ohe
Published 2019-04-01

Malignant pleural effusion as a predictor of the efficacy of anti‐PD‐1 antibody in patients with non‐small cell lung cancer

by Ryota Shibaki, Shuji Murakami, Yuki Shinno, Yuji Matsumoto, Yasushi Goto, Shintaro Kanda, Hidehito Horinouchi, Yutaka Fujiwara, Noriko Motoi, Noboru Yamamoto, Yuichiro Ohe
Published 2019-04-01

Phase II trial of S‐1 treatment as palliative‐intent chemotherapy for previously treated advanced thymic carcinoma

by Yusuke Okuma, Yasushi Goto, Fumiyoshi Ohyanagi, Kuniko Sunami, Yoshiro Nakahara, Satoru Kitazono, Keita Kudo, Yuichi Tambo, Shintaro Kanda, Noriko Yanagitani, Atsushi Horiike, Hidehito Horinouchi, Yutaka Fujiwara, Hiroshi Nokihara, Noboru Yamamoto, Makoto Nishio, Yuichiro Ohe, Yukio Hosomi
Published 2020-10-01